Annabelle's Challenge is the leading charity for vascular Ehlers-Danlos syndrome in the UK, we also provide support globally. We are proud to receive The Queen's Award for Voluntary Service.
Our charity is totally focused on raising awareness to the general public and medical profession to help aid an early diagnosis and prevent misdiagnosis of vascular EDS a rare life limiting genetic condition. We also provide support to patients and families touched by vascular EDS.
COL3A1 gene is the instruction for making collagen type III a tough fibre-like protein that makes up a third of our body protein. When this gene is altered, it causes a lack or deficiency of this collagen making the connective tissue less effective, particularly in skin, lung, uterus, intestine and the vascular system.
Because many individuals with vascular EDS (vEDS) are identified only after a severe complication or death, it is likely it did not come to medical attention and therefore goes undetected.
At present, the life span for affected individuals is a median age of about 51 years (49 for males and 53 for females) but with a very large range from 10 years to 80 years. The prevalence is estimated as 1/50,000 to 1/200,000.
It is a rare genetic condition and therefore many health professionals will not have seen someone with this diagnosis.
The diagnosis of vascular EDS carries with it the life threatening risks of blood vessel and organ rupture, sometimes in childhood.
The clinical features typical of vascular EDS may be subtle or absent, making diagnosis difficult particularly where there is no positive family history. Sudden death in the third or fourth decade of life can be the presenting feature.
The aim of Annabelle's Challenge is to raise awareness, support patients and families affected by vascular EDS and to encourage the medical profession to progress further with research into finding a cure.
If you are concerned about vascular EDS or require any further information please contact us we are here to support you.
Freephone helpline: 0800 917 8495
Education: To advance the education of the general public and medical profession in all areas relating to vascular Ehlers-Danlos syndrome.
Research: The relief of sickness and preservation and protection of good health by the provision of funding for the development of research and early diagnosis of vascular Ehlers-Danlos syndrome.
Support: To promote and protect the physical and good mental health of sufferers of vascular Ehlers-Danlos syndrome through the provision of financial assistance, support, education and practical advice.
During January 2018 we surveyed our members to gain their feedback on the charity and focus areas going forward.
We have utilised the results of the survey and taken on board the concerns of our patients and families to implement a clear vision for the charity over the next three years.
Our four key goals we aim to deliver by 2021:
Your donations help us to raise awareness of life threatening vascular EDS and to support patients and families who are affected by the condition.
Funds raised also help us to provide advice, support, and education of the condition, we also provide grants and free MedicAlert UK membership for diagnosed patients.
The funds raised are put to very good use to help towards;
We also support our local community in Bury, the hometown of our charity and delighted to sponsor the 'Bury Thunder' netball team and proud to be a Bury Mayoral chosen charity for 2016/17.
Proudly supporting the NHS EDS National Diagnostic Service
Please note Annabelle's Challenge does not provide medical advice, you should contact your local doctor or GP with any medically related concerns or questions.
The information contained on this website is obtained from various reliable sources and should not be construed to represent opinion or advice by Annabelle’s Challenge and/or it's trustees.
Annabelle's Challenge values your support and promises to respect your privacy. The data we gather and hold is managed in accordance with the General Data Protection Regulation (GDPR) effective from 25th May 2018.